DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss the key benefits of continuous glucose monitoring (CGM) technology compared with ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.
Woman's World on MSN2d
Struggling With Belly Fat? Over-The-Counter Glucose Monitors Can HelpAny time we try a healthy new way of eating, it’s easy for doubt to creep in. Is it really working? Is it worth it? Does it ...
This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss how continuous glucose monitoring (CGM) adoption impacts clinical inertia and ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback